JENNIFER JACOBS: Open Payments
NPI 1134622806 · DOVER, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 33 payments from 9 companies in 2025. Trend: 2023 $124 · 2024 $191 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $139 |
| Axsome Therapeutics, Inc. | 5 | $127 |
| Paratek Pharmaceuticals, Inc. | 4 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Exact Sciences Corporation | 2 | $28 |
| Novo Nordisk Inc | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| UCB, Inc. | 1 | $14 |
Products named: VRAYLAR, Auvelity, NUZYRA, CAPLYTA, Wegovy, XHANCE, GVOKE HYPOPEN, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
